Toxicity and Treatment Completion of Neoadjuvant FOLFOXIRI and Chemoradiotherapy in Patients With High-Risk Locally Advanced Rectal Cancer: A Secondary Outcome Analysis of the MEND-IT Trial.
Saved in:
| Title: | Toxicity and Treatment Completion of Neoadjuvant FOLFOXIRI and Chemoradiotherapy in Patients With High-Risk Locally Advanced Rectal Cancer: A Secondary Outcome Analysis of the MEND-IT Trial. |
|---|---|
| Authors: | Banken, Evi1,2,3 (AUTHOR) evi.banken@catharinaziekenhuis.nl, van den Berg, Kim1,3 (AUTHOR), van Hellemond, Irene E.G.1 (AUTHOR), Peulen, Heike M.U.4 (AUTHOR), Nederend, Joost5 (AUTHOR), Steller, Ernst J.A.6 (AUTHOR), de Groot, Jan Willem B.7 (AUTHOR), Verhoef, Cornelis8 (AUTHOR), Aalbers, Arend G.J.9 (AUTHOR), Vincent, Jeroen10 (AUTHOR), Buffart, Tineke E.11 (AUTHOR), Werter, Inge M.12 (AUTHOR), Douma, Joeri A.J.13 (AUTHOR), Bloemen, Johanne G.2 (AUTHOR), Burger, Jacobus W.A.2,3 (AUTHOR) |
| Source: | International Journal of Radiation Oncology, Biology, Physics. Jul2026, Vol. 125 Issue 4, p1008-1017. 10p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
